# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-23-000208
Filing Date
2023-12-11
Accepted
2023-12-11 07:24:51
Documents
105
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | ebs-20230930.htm iXBRL | 10-Q | 2627372
2 | EX-10.1 | emergentbiosolutionsincind.htm | EX-10.1 | 118266
3 | EX-10.2 | formofletteragreementdated.htm | EX-10.2 | 35491
4 | EX-31.1 | a311-millercert093023.htm | EX-31.1 | 8500
5 | EX-31.2 | a312-lindhalcert093023.htm | EX-31.2 | 8564
6 | EX-32.1 | a321-millercert093023.htm | EX-32.1 | 3550
7 | EX-32.2 | a322-lindhalcert093023.htm | EX-32.2 | 3400
13 |  | ebs-20230930_g1.jpg | GRAPHIC | 75656
14 |  | image.jpg | GRAPHIC | 7369
| Complete submission text file | 0001367644-23-000208.txt |  | 13869171

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | ebs-20230930.xsd | EX-101.SCH | 57887
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | ebs-20230930_cal.xml | EX-101.CAL | 78065
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | ebs-20230930_def.xml | EX-101.DEF | 450855
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | ebs-20230930_lab.xml | EX-101.LAB | 798970
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | ebs-20230930_pre.xml | EX-101.PRE | 668444
99 | EXTRACTED XBRL INSTANCE DOCUMENT | ebs-20230930_htm.xml | XML | 2741999

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 231476907
SIC: 2834 Pharmaceutical Preparations